Clinical Trials Directory

Trials / Sponsors / GenSight Biologics

GenSight Biologics

Industry · 9 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
RecruitingEfficacy and Safety Study of Bilateral IVT Injection of GS010 at Two Dose Levels in LHON Patients
Leber Hereditary Optic Disease
Phase 22026-01-22
Active Not RecruitingDose-escalation Study to Evaluate the Safety and Tolerability of GS030 in Subjects With Retinitis Pigmentosa
Non-syndromic Retinitis Pigmentosa
Phase 1 / Phase 22018-09-26
CompletedEfficacy & Safety Study of Bilateral IVT Injection of GS010 in LHON Subjects Due to the ND4 Mutation for up to
Leber Hereditary Optic Neuropathy
Phase 32018-03-12
CompletedRESCUE and REVERSE Long-term Follow-up
Leber Hereditary Optic Neuropathy
Phase 32018-01-09
CompletedREALITY LHON Registry
Leber Hereditary Optic Neuropathy
—2018-01-03
CompletedEfficacy Study of GS010 for the Treatment of Vision Loss up to 6 Months From Onset in LHON Due to the ND4 Muta
Optic, Atrophy, Hereditary, Leber
Phase 32016-02-23
CompletedEfficacy Study of GS010 for Treatment of Vision Loss From 7 Months to 1 Year From Onset in LHON Due to the ND4
Optic, Atrophy, Hereditary, Leber
Phase 32016-01-01
CompletedSafety Evaluation of Gene Therapy in Leber Hereditary Optic Neuropathy (LHON) Patients
Leber Hereditary Optic Neuropathy
Phase 1 / Phase 22014-02-13
No Longer AvailableEAP_GS010_single Patient
Leber Hereditary Optic Neuropathy (Optic, Atrophy, Hereditary, Leber)
——